Expression of N-Terminal Cysteine Aβ42 and Conjugation to Generate Fluorescent and Biotinylated Aβ42
- 1 April 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 60 (15) , 1191-1200
Abstract
Fluorescent derivatives of the β-amyloid peptides (Aβ) are valuable tools for studying the interactions of Aβ with cells. Facile access to labeled expressed Aβ offers the promise of Aβ with greater sequence and stereochemical integrity, without impurities from amino acid deletion and epimerization. Here, we report methods for the expression of Aβ42 with an N-terminal cysteine residue, Aβ(C1–42), and its conjugation to generate Aβ42 bearing fluorophores or biotin. The methods rely on the hitherto unrecognized observation that expression of the Aβ(MC1–42) gene yields the Aβ(C1–42) peptide, because the N-terminal methionine is endogenously excised by Escherichia coli. Conjugation of Aβ(C1–42) with maleimide-functionalized fluorophores or biotin affords the N-terminally labeled Aβ42. The expression affords ∼14 mg of N-terminal cysteine Aβ from 1 L of bacterial culture. Subsequent conjugation affords ∼3 mg of labeled Aβ from 1 L of bacterial culture with minimal cost for labeling reagents. High-performance liquid chromatography analysis indicates the N-terminal cysteine Aβ to be >97% pure and labeled Aβ peptides to be 94–97% pure. Biophysical studies show that the labeled Aβ peptides behave like unlabeled Aβ and suggest that labeling of the N-terminus does not substantially alter the properties of the Aβ. We further demonstrate applications of the fluorophore-labeled Aβ peptides by using fluorescence microscopy to visualize their interactions with mammalian cells and bacteria. We anticipate that these methods will provide researchers convenient access to useful N-terminally labeled Aβ, as well as Aβ with an N-terminal cysteine that enables further functionalization.Keywords
Funding Information
- National Institute on Aging (AG062296)
- National Institute of General Medical Sciences (GM097562)
This publication has 65 references indexed in Scilit:
- Cerebrospinal Aβ11-x and 17-x levels as indicators of mild cognitive impairment and patients’ stratification in Alzheimer’s diseaseTranslational Psychiatry, 2013
- Single Molecule Characterization of the Interactions between Amyloid-β Peptides and the Membranes of Hippocampal CellsJournal of the American Chemical Society, 2013
- Distinct modulation of microglial amyloid β phagocytosis and migration by neuropeptidesiJournal of Neuroinflammation, 2010
- Synaptotoxicity of Alzheimer Beta Amyloid Can Be Explained by Its Membrane Perforating PropertyPLOS ONE, 2010
- The Recombinant Amyloid-β Peptide Aβ1–42 Aggregates Faster and Is More Neurotoxic than Synthetic Aβ1–42Journal of Molecular Biology, 2010
- Preparation of fluorescently‐labeled amyloid‐beta peptide assemblies: the effect of fluorophore conjugation on structure and functionJournal of Molecular Recognition, 2009
- Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease MiceThe Journal of Neuroscience, 2008
- ApoE Promotes the Proteolytic Degradation of AβNeuron, 2008
- Degradation of fibrillar forms of Alzheimer's amyloid β-peptide by macrophagesNeurobiology of Aging, 2008
- Lipocalin-type prostaglandin D synthase/β-trace is a major amyloid β-chaperone in human cerebrospinal fluidProceedings of the National Academy of Sciences, 2007